THE SCHEDULE 13G

Company

Corvus Pharmaceuticals, Inc.

Filed

March 19, 2018

Accession Number

0000921895-18-001020

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →